ArticleLangmuir : the ACS journal of surfaces and colloids2025
Bioinert Fibrous Polypropylene Membranes via In Situ Polymerization of Zwitterionic Poly(sulfobetaine methacrylate).
Article in Langmuir : the ACS journal of surfaces and colloids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antithrombotic Polymers: A Narrative Review on Current and Future Strategies for Their Design, Synthesis, and Application.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study reports the fabrication of a biocompatible polypropylene (PP) fibrous membrane via an in situ polymerization process, generating a dual network of PP fibers and poly(sulfobetaine methacrylate) (poly(SBMA)). In this method, the synthesis of the polymer and the modification process happen in a single step. Notably, the modification was achieved without the incorporation of hydrophobic groups in the modifying polymer, demonstrating that the physical entanglement of poly(SBMA) and PP was sufficient to produce a stable biocompatible membrane. The presence of the poly(SBMA) coating was confirmed through various characterization techniques. A reduction in the water contact angle indicated increased hydrophilicity, while Fourier-transform infrared spectroscopy and X-ray photoelectron spectroscopy analyses verified the presence of poly(SBMA) on the PP membrane surface. The PP membranes were modified with varying sulfobetaine methacrylate solid. The physical morphology of the modified membranes was observed via SEM, and it was seen that membranes modified with higher solid content (4.00, 7.50, 15.0, and 30.0 wt %) showed significant polymer aggregates, making the membranes significantly denser than the original PP membrane. Therefore, optimal modification was achieved with 1.00 wt % poly(SBMA), which balanced enhanced hydrophilicity with preservation of the structural integrity of the membrane. This modification resulted in a 70% reduction in bacterial (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.